Forxiga generics occupy 20% of mkt 2 mths into their release
By Kim, Jin-Gu | translator Kim, Jung-Ju
23.06.18 14:15:28
가나다라
0
Prescriptions of Forxiga and Xigduo amount to KRW 8.8 billion in May...generics sell KRW 2.2 billion
Many generic drugs enter the market in April...60 single-agent drugs and 31 combination drugs released
Market size exceeds KRW 10 million...average prescription amount of the generic drugs reaches KRW 20 million
▲Forxiga (left), Pic of Xigduo
‘Forxiga (dapagliflozin)’ generics have increased their market share to 20% within 2 months of entry into the market.
With fierce competition unfolding in the prescription field, the total market size expanded to exceed KRW 10 billion per month. However, since so many products were released at the same time, the average monthly prescription amount per generic product amounted to only around KRW 20 million.
According to the marker research institution UBIST on the 19th, the outpatient prescription amount of single-agent and combination dapagliflozin drugs was KRW 11 billion in May.
The original drugs, Forxiga and Xigduo posted sales of KRW 8.8 billion, and the c
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)